ConductScience.org, home

Trial · NCT03467217

Registered outcomes17

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Serum Alanine Aminotransferase (ALT) From Baseline.Baseline and 24 weeksChange ALT value in U/L (24 weeks minus baseline). A negative score indicates improvement.
SecondaryChange in Gamma-glutamyl Transpeptidase (GGT) Compared to BaselineBaseline and 24 weeksChange from baseline in gamma-glutamyl transpeptidase (GGT), measured in U/L.
SecondaryChange in Serum Aspartate Aminotransferase AST at 24 Weeks Compared to Baseline ASTBaseline and 24 weeksChange from baseline in serum aspartate aminotransferase, measured in U/L.
SecondaryRelative Change in Serum Alanine Aminotransferase (ALT) Compared to Baseline ALTBaseline and 24 weeksRelative change from baseline in serum ALT, measured in percentage of change.
SecondaryChange in ALT at 12 Weeks Compared to Baseline ALTBaseline and 12 weeksChange from baseline in ALT at 12 weeks, measured in U/L.
SecondaryChange in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) Compared to Baseline.Baseline and 24 weeks
Homeostasis Model Assessment of Insulin Resistance Index (HOMA-IR) measures insulin resistance, calculated by fasting insulin (umol/mL) multiplied by fasting glucose (mg/dL), and divided by a constant (405). A higher score indicates higher insulin resistance.
SecondaryChange in Weight at 24 Weeks Compared to BaselineBaseline and 24 weeksChange from baseline in weight, measured in kg.
SecondaryChange in Body Mass Index (BMI) at 24 Weeks Compared to Baseline.Baseline and 24 weeksChange from baseline in BMI, measured in kg/m\^2.
SecondaryChange in Waist Circumference at 24 Weeks Compared to BaselineBaseline and 24 weeksChange from baseline in waist circumference, measured in centimeters.
SecondaryChange in Waist-to-hip Ratio at 24 Weeks Compared to BaselineBaseline and 24 weeksChange from baseline in waist-to-hip ratio, measured as the circumference of the waist in centimeters divided by the circumference of the hips in centimeters.
SecondaryChange in Pediatric Quality of Life Inventory (PedsQOL) Physical Health Score at 24 Weeks Compared to BaselineBaseline and 24 weeks
Pediatric Quality of Life Inventory (PedsQOL) version 4.0 is composed of 23 items comprising 4 dimensions: Physical Functioning, Emotional Functioning, Social Functioning, and School Functioning. Scores are transformed on a scale from 0 to 100, with higher scores indicating better health-related quality of life. Physical Health Summary Score =Physical Functioning Scale Score. The outcome is 24-week change from baseline in PedsQOL Physical Health Score, where higher values indicate improvement in quality of life.
SecondaryFrequency of Adverse Events Over 24 WeeksBaseline and 24 weeksNumbers of adverse events reported over 24 weeks.
SecondaryChange in Total Cholesterol at 24 Weeks Compared to BaselineBaseline and 24 weeksChange from baseline in total cholesterol, measured in mg/dL
SecondaryChange in Triglycerides at 24 Weeks Compared to BaselineBaseline and 24 weeksChange from baseline in triglycerides, measured in mg/dL
SecondaryChange in HDL Cholesterol at 24 Weeks Compared to BaselineBaseline and 24 weeksChange from baseline in HDL cholesterol, measured in mg/dL
SecondaryChange in LDL Cholesterol at 24 Weeks Compared to BaselineBaseline and 24 weeksChange from baseline in LDL cholesterol, measured in mg/dL
SecondaryChange in Pediatric Quality of Life Inventory (PedsQOL) Psychosocial Health Score at 24 Weeks Compared to BaselineBaseline and 24 weeks
Pediatric Quality of Life Inventory (PedsQOL) version 4.0 is composed of 23 items comprising 4 dimensions: Physical Functioning, Emotional Functioning, Social Functioning, and School Functioning. Scores are transformed on a scale from 0 to 100, with higher scores indicating better health-related quality of life. Psychosocial Health Summary Score = Sum of items over the number of items answered in the Emotional, Social, and School Functioning Scales. The outcome is 24-week change from baseline in PedsQOL Psychosocial Health Score, where higher values indicate improvement in quality of life.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03467217/registered